Nationwide Trends in the Incidence and Outcome of Patients With Gastrointestinal Stromal Tumour in the Imatinib Era

British Journal of Surgery - United States
doi 10.1002/bjs.10809
Full Text
Abstract

Available in full text

Categories
Surgery
Date
Authors
Publisher

Wiley

Related search

Relative Hypocalcaemia and Muscle Cramps in Patients Receiving Imatinib for Gastrointestinal Stromal Tumour

Sarcoma
Nuclear MedicineRadiologyImagingOncology
2006English

Sunitinib Malate for Gastrointestinal Stromal Tumour in Imatinib Mesylate–resistant Patients: Recommendations and Evidence

Current Oncology
Oncology
2010English

Gastrointestinal Stromal Tumors Treated With Imatinib Mesylate: Apparent Diffusion Coefficient in the Evaluation of Therapy Response in Patients

Radiology
Nuclear MedicineRadiologyImaging
2011English

Severe Esophagitis in a Patient With Gastrointestinal Stromal Tumor Treated With Imatinib

Endoscopy
Gastroenterology
2009English

Splenosis With Lower Gastrointestinal Bleeding Mimicking Colonical Gastrointestinal Stromal Tumour

World Journal of Surgical Oncology
SurgeryOncology
2017English

Surgical Treatment and Prognostic Analysis for Gastrointestinal Stromal Tumors (GISTs) of the Small Intestine: Before the Era of Imatinib Mesylate

BMC Gastroenterology
MedicineGastroenterology
2006English

Paraneoplastic Pemphigus Associated With Malignant Gastrointestinal Stromal Tumour

Acta Dermato-Venereologica
DermatologyMedicine
2010English

Optimizing Surgical and Imatinib Therapy for the Treatment of Gastrointestinal Stromal Tumors

Journal of Gastrointestinal Surgery
SurgeryGastroenterology
2013English

The Economic Burden of Gastrointestinal Stromal Tumor (GIST) Recurrence in Patients Who Have Received Adjuvant Imatinib Therapy

Journal of Medical Economics
Health Policy
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy